Skip to main content

Table 1 Demographic data and underlying diseases of intensive care unit patients with bronchoalveolar lavage lateral-flow-device test resultsa

From: Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients

 

Present study population

Graz

Innsbruck

Vienna

Mannheim

Number of BALs/patients

149/133

70/61

51/49

18/13

10/10

Sex

     

 Male

87 (65.4%)

45 (51.7%)

28 (32.2%)

6 (6.9%)

8 (9.2%)

 Female

46 (34.6%)

16 (34.8%)

21 (45.7%)

7 (15.2%)

2 (4.3%)

Median age (range)

60 (19 to 85)

66 (19 to 83)

58 (26 to 85)

59.5 (41 to 74)

55.5 (40 to 75)

Type of ICU admission (BALs)

     

 Medical

121/149 (81.2%)

60/70 (85.7%)

35/51 (68.6%)

16/18 (88.9%)

10/10 (100%)

 Neurologic

6/149 (4%)

5/70 (2.9%)

1/51 (2%)

 Elective surgery

2/149 (1.3%)

1/51 (2%)

1/18 (5.6%)

 Emergency surgery

8/149 (5.4%)

4/70 (5.7%)

4/51 (7.8%)

 Trauma

12/149 (8.1%)

1/70 (1.4%)

10/51 (19.6%)

1/18 (5.6%)

Primary underlying disease (BALs)

     

 Pulmonary disease

44/149 (29.5%)

21/70 (30%)

14/51 (27.5%)

6/18 (33.3%)

3/10 (30%)

 Heart disease

25/149 (16.8%)

17/70 (24.3%)

4/51 (7.8%)

4/18 (22.2%)

 Hematologic malignancies

19/149 (12.8%)

8/70 (11.4%)

3/51 (5.9%)

2/18 (11.1%)

6/10 (60%)

 Trauma

12/149 (8.1)

1/70 (1.4%)

10/51 (19.6%)

1/18 (5.6%)

 Neurologic disease

14/149 (9.4%)

11/70 (15.7%)

3/51 (5.9%)

 Gastrointestinal disease

13/149 (8.7%)

3/70 (4.3%)

7/51 (13.7%)

3/18 (16.7%)

 Metabolic disease

4/149 (2.7%)

1/70 (1.4%)

3/51 (5.9%)

 Other malignancies

5/149 (3.4%)

3/70 (4.3%)

2/51 (3.9%)

 Rheumatologic disease

4/149 (2.7%)

3/70 (4.3%)

1/10 (10%)

 Others

9/149 (6%)

2/70 (2.9%)

5/51 (9.8%)

2/18 (11.1%)

IPA classification

     

 Proven IPA (BALs/patients)

4/2

3/1

1/1

 Probable IPA (BALs/patients)

16/14

6/6

8/7

2/1

 Possible IPA (BALs/patients)

21/20

6/5

6/6

9/9

 No IPA (BALs/patients)

108/97

58/50

37/36

13/11

  1. aBAL, Bronchoalveolar lavage; COPD, Chronic obstructive pulmonary disease; IPA, Invasive pulmonary aspergillosis.